Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Methyl salicylate 2-ethylbutyrate is an ester derivative of salicylic acid, produced by the esterification of salicylic acid with methanol and 2-ethylbutyric acid. It is used in cosmetics for its wintergreen fragrance and as a flavoring agent in foods, beverages, candies, chewing gums, and oral care products. In pharmaceuticals, it serves as an active ingredient in topical anesthetics to promote relief of muscle and arthritis pain. Its mechanism of action is similar to other topical counterirritants; it acts primarily by causing irritation of sensory nerve endings which alters or masks musculoskeletal pain through counter-irritation. When applied topically, it may also reversibly inhibit cyclooxygenase enzyme locally to reduce the production of inflammatory mediators such as prostaglandins[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methyl salicylate 2-ethylbutyrate.